DR Congo Ebola vaccine trial to begin within weeks: WHO

Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will go through a full-scale human trial in the DRC to see if it offers any cross-protection against Bundibugyo
Read the full story on The Hindu Opens thehindu.com in a new tab
Advertisement
Tech RajeshwarNeed a new website?Websites & apps built for your business — contact Tech RajeshwarContact us
This is a short summary of a story published by The Hindu, shown with a link to the original. The full story, photo and reporting belong to The Hindu.










